Neprilysin as a Biomarker: Challenges and Opportunities
Neprilysin (NEP) inhibition is a successful novel therapeutic approach in heart failure with reduced ejection fraction. Assessing individual NEP status might be important for gathering insights into mechanisms of disease and optimising individualised patient care. NEP is a zinc-dependent multisubstr...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Radcliffe Medical Media
2020-08-01
|
| シリーズ: | Cardiac Failure Review |
| オンライン･アクセス: | https://www.cfrjournal.com/articles/neprilysin-as-a-biomarker |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|